Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Greater weight loss from GLP-1 drugs lowers health complication risk

10

May 2026

Greater weight loss from GLP-1 drugs lowers health complication risk

New research to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) shows that, following treatment for obesity or diabetes or both using incretin-based drugs, losing more weight versus less weight, and losing a little weight versus gaining weight, both lead to relatively lower risk of obesity-related conditions.

Children frequently pressure parents to buy unhealthy foods during shopping

10

May 2026

Children frequently pressure parents to buy unhealthy foods during shopping

A study using a nationally representative survey of parents in England, to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May), reveals that over half (58%) of parents are frequently pestered by their children or teens to purchase products high in fats, salts and/or sugar (HFSS) when food shopping in stores or online, and almost three-quarters (72%) reported often buying the requested item.

Walking 8,500 steps daily may help prevent weight regain

10

May 2026

Walking 8,500 steps daily may help prevent weight regain

New research being presented at this year's European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) and published in International Journal of Environmental Research and Public Health shows that doing around 8,500 steps a day can help people keep weight off after dieting.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.